PredictrPK® ADA, a Precision-Guided Dosing Test Supporting Adalimumab Treatment Optimization, Demonstrates Strong Clinical Utility in New Study
News & Events PredictrPK® ADA, [...]
Prometheus Laboratories Presents Novel Data on Precision-Guided Care in IBD at DDW® 2025
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Launches First Pre-Therapy Test to Predict Likelihood of Biologic Response
News & Events Prometheus Laboratories [...]
Prometheus Laboratories Launches New Anser® Test for Risankizumab
News & Events Prometheus [...]
Prometheus Laboratories Unveils New Data on Precision-Guided Care for IBD at ECCO’25 Congress
News & Events Prometheus [...]
Prometheus Laboratories Presents Data Demonstrating Clinical Validity, Utility, and Positive Economic Impact of Precision-Guided Care at DDW® 2024
News & Events Prometheus [...]
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
News & Events Prometheus [...]
Prometheus Laboratories Announces a Major Milestone in Demonstrating Clinical Utility of Precision-Guided Dosing for Optimizing IBD Patient Care and Cost Savings
News & Events Prometheus [...]
Prometheus Laboratories Surpasses 35 Million Covered Lives Under Positive Medical Policy for Anser® Therapeutic Drug Monitoring
News & Events Prometheus [...]
Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser® Testing
News & Events Prometheus [...]